Metronidazol Baxter Viaflo 5 mg/ ml Norge - norsk - Statens legemiddelverk

metronidazol baxter viaflo 5 mg/ ml

baxter medical ab - metronidazol - infusjonsvæske, oppløsning - 5 mg/ ml

Flagyl 5 mg/ ml Norge - norsk - Statens legemiddelverk

flagyl 5 mg/ ml

sanofi-aventis norge (3) - metronidazolbenzoat - infusjonsvæske, oppløsning - 5 mg/ ml

Metronidazole Braun 5 mg/ ml Norge - norsk - Statens legemiddelverk

metronidazole braun 5 mg/ ml

b. braun melsungen ag - metronidazol - infusjonsvæske, oppløsning - 5 mg/ ml

Enhertu Den europeiske union - norsk - EMA (European Medicines Agency)

enhertu

daiichi sankyo europe gmbh - trastuzumab deruxtecan - bryst neoplasms - antineoplastiske midler - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Tetravac Norge - norsk - Statens legemiddelverk

tetravac

sanofi pasteur europe - difteritoksoid / clostridium tetani, toksoid / pertussistoksoid / filamentøst hemagglutinin / poliovirus type 1, inaktivert / poliovirus type 2, inaktivert / poliovirus type 3, inaktivert - injeksjonsvæske, suspensjon - 30 ie/ sprøyte / 40 ie/ sprøyte / 25 mikrog/ sprøyte / 25 mikrog/ sprøyte / 40 d-antigen enheter/ sprøyte / 8 d-antigen enheter/

Dovprela (previously Pretomanid FGK) Den europeiske union - norsk - EMA (European Medicines Agency)

dovprela (previously pretomanid fgk)

mylan ire healthcare limited - pretomanid - tuberkulose, multidrug-resistent - antimykobakterielle - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Citalopram Sandoz 10 mg Norge - norsk - Statens legemiddelverk

citalopram sandoz 10 mg

sandoz (2) - citalopramhydrobromid - tablett, filmdrasjert - 10 mg

Citalopram Sandoz 20 mg Norge - norsk - Statens legemiddelverk

citalopram sandoz 20 mg

sandoz (2) - citalopramhydrobromid - tablett, filmdrasjert - 20 mg

Citalopram Sandoz 40 mg Norge - norsk - Statens legemiddelverk

citalopram sandoz 40 mg

sandoz (2) - citalopramhydrobromid - tablett, filmdrasjert - 40 mg

Conoxia 100 % Norge - norsk - Statens legemiddelverk

conoxia 100 %

linde gas - oksygen - medisinsk gass, kryogen - 100 %